Release Date: 04/02/10 09:24 Summary: CWT 1H10 Operating profit after tax $7.3 million Price Sensitive: No Download Document 52.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%